The Annals Evolution of Clinical Pharmacy | Now Available
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 18 November 2008, www.theannals.com, DOI 10.1345/aph.1L319.
This Article
Right arrow PDF
Right arrow For Our Patients
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Reinhart, K. M
Right arrow Articles by White, C M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Reinhart, K. M
Right arrow Articles by White, C M.


RESEARCH REPORTS

Effects of Garlic on Blood Pressure in Patients With and Without Systolic Hypertension: A Meta-Analysis (December)

Kurt M Reinhart PharmD1, Craig I Coleman PharmD2, Colleen Teevan BSPharm,3, Payal Vachhani BSPharm4, C Michael White PharmD5*

1 Fellow, Cardiovascular Outcomes, Hartford Hospital, Hartford, CT
2 Methods Chief, Health Outcomes, Policy, and Economics Collaborative Group, University of Connecticut and Hartford Hospital
3 PharmD Student, School of Pharmacy, University of Connecticut, Storrs, CT
4 PharmD Student, School of Pharmacy, University of Connecticut
5 Director, Health Outcomes, Policy, and Economics Collaborative Group, University of Connecticut and Hartford Hospital

* To whom correspondence should be addressed. E-mail: cmwhite{at}harthosp.org.


   Abstract

BACKGROUND: Garlic has been suggested to lower blood pressure; however, studies evaluating this parameter have provided conflicting results.

OBJECTIVE: To examine the effect of garlic on blood pressure in patients with and without elevated systolic blood pressure (SPB) through meta-analyses of randomized controlled trials.

METHODS: A systematic search of MEDLINE, CINAHL, and the Cochrane Central Register of Controlled Trials was conducted to identify randomized controlled trials in humans evaluating garlic's effect on blood pressure. All databases were searched from their inception through June 26, 2008, using the key words garlic, Allium sativum, and allicin. A manual search of published literature was used to identify additional relevant studies. To be included in the analysis, studies must have been written in English or German and reported endpoints of SBP or diastolic blood pressure (DBP). Studies whose population ad a mean baseline SBP greater than 140 mm Hg were evaluated separately from those whose population had lower baseline blood pressures. Garlic's effect on SBP and DBP was treated as a continuous variable and weighted mean differences were calculated using a random-effects model.

RESULTS: Ten trials were included in the analysis; 3 of these had patients with elevated SBP. Garlic reduced SBP by 16.3 mm Hg (95% CI 6.2 to 26.5) and DBP by 9.3 mmHg (95% CI 5.3 to 13.3) compared with placebo in patients with elevated SBP. However, the use of garlic did not reduce SBP or DBP in patients without elevated SBP. There was only a minor degree of heterogeneity in the analyses and publication bias did not appear to influence the results.

CONCLUSIONS: This meta-analysis suggests that garlic is associated with blood pressure reductions in patients with an elevated SBP although not in those without elevated SBP. Future research should focus on the impact of garlic on clinical events and the assessment of the long-term risk of harm.

Key Words: allicin, antihypertensive agents, garlic, herbals, hypertension, meta-analysis.

Reprints:Dr. White, University of Connecticut and Hartford Hospital, 80 Seymour St., Hartford, CT 06102, fax 860/545-2277, cmwhite@harthosp.org







homecopy help contact us subscription past issues search current issue
Copyright © 2008 by Harvey Whitney Books Company.